These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 18487222

  • 1. Prohibitin and the SWI/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes.
    Dai Y, Ngo D, Jacob J, Forman LW, Faller DV.
    Carcinogenesis; 2008 Sep; 29(9):1725-33. PubMed ID: 18487222
    [Abstract] [Full Text] [Related]

  • 2. A competitive inhibitor that reduces recruitment of androgen receptor to androgen-responsive genes.
    Cherian MT, Wilson EM, Shapiro DJ.
    J Biol Chem; 2012 Jul 06; 287(28):23368-80. PubMed ID: 22589544
    [Abstract] [Full Text] [Related]

  • 3. Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP.
    Mita P, Savas JN, Djouder N, Yates JR, Ha S, Ruoff R, Schafler ED, Nwachukwu JC, Tanese N, Cowan NJ, Zavadil J, Garabedian MJ, Logan SK.
    Mol Cell Biol; 2011 Sep 06; 31(17):3639-52. PubMed ID: 21730289
    [Abstract] [Full Text] [Related]

  • 4. Differential requirement of SWI/SNF for androgen receptor activity.
    Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE.
    J Biol Chem; 2003 Aug 15; 278(33):30605-13. PubMed ID: 12775722
    [Abstract] [Full Text] [Related]

  • 5. Manipulating prohibitin levels provides evidence for an in vivo role in androgen regulation of prostate tumours.
    Dart DA, Spencer-Dene B, Gamble SC, Waxman J, Bevan CL.
    Endocr Relat Cancer; 2009 Dec 15; 16(4):1157-69. PubMed ID: 19635783
    [Abstract] [Full Text] [Related]

  • 6. Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.
    Liu S, Qi Y, Ge Y, Duplessis T, Rowan BG, Ip C, Cheng H, Rennie PS, Horikawa I, Lustig AJ, Yu Q, Zhang H, Dong Y.
    Mol Cancer Ther; 2010 Jul 15; 9(7):2016-25. PubMed ID: 20571066
    [Abstract] [Full Text] [Related]

  • 7. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors.
    Hodgson MC, Astapova I, Hollenberg AN, Balk SP.
    Cancer Res; 2007 Sep 01; 67(17):8388-95. PubMed ID: 17804755
    [Abstract] [Full Text] [Related]

  • 8. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
    Shi XB, Xue L, Zou JX, Gandour-Edwards R, Chen H, deVere White RW.
    Prostate; 2008 Dec 01; 68(16):1816-26. PubMed ID: 18780293
    [Abstract] [Full Text] [Related]

  • 9. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
    Kang Z, Jänne OA, Palvimo JJ.
    Mol Endocrinol; 2004 Nov 01; 18(11):2633-48. PubMed ID: 15308689
    [Abstract] [Full Text] [Related]

  • 10. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
    Jin F, Fondell JD.
    Nucleic Acids Res; 2009 Aug 01; 37(14):4826-38. PubMed ID: 19520769
    [Abstract] [Full Text] [Related]

  • 11. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
    Gravina GL, Festuccia C, Millimaggi D, Dolo V, Tombolini V, de Vito M, Vicentini C, Bologna M.
    Prostate; 2008 May 15; 68(7):793-801. PubMed ID: 18324645
    [Abstract] [Full Text] [Related]

  • 12. Sirtuin 1 is required for antagonist-induced transcriptional repression of androgen-responsive genes by the androgen receptor.
    Dai Y, Ngo D, Forman LW, Qin DC, Jacob J, Faller DV.
    Mol Endocrinol; 2007 Aug 15; 21(8):1807-21. PubMed ID: 17505061
    [Abstract] [Full Text] [Related]

  • 13. Targeting the BAF57 SWI/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity.
    Link KA, Balasubramaniam S, Sharma A, Comstock CE, Godoy-Tundidor S, Powers N, Cao KH, Haelens A, Claessens F, Revelo MP, Knudsen KE.
    Cancer Res; 2008 Jun 15; 68(12):4551-8. PubMed ID: 18559499
    [Abstract] [Full Text] [Related]

  • 14. FOXA1 regulates androgen receptor variant activity in models of castrate-resistant prostate cancer.
    Jones D, Wade M, Nakjang S, Chaytor L, Grey J, Robson CN, Gaughan L.
    Oncotarget; 2015 Oct 06; 6(30):29782-94. PubMed ID: 26336819
    [Abstract] [Full Text] [Related]

  • 15. Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor.
    Wang Y, Liu G, Tong D, Parmar H, Hasenmayer D, Yuan W, Zhang D, Jiang J.
    Prostate; 2015 Aug 01; 75(11):1187-96. PubMed ID: 25894097
    [Abstract] [Full Text] [Related]

  • 16. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
    Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H.
    Cancer Res; 1994 Oct 15; 54(20):5474-8. PubMed ID: 7522959
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the androgen receptor as a novel mechanism of taxol chemotherapy in prostate cancer.
    Gan L, Chen S, Wang Y, Watahiki A, Bohrer L, Sun Z, Wang Y, Huang H.
    Cancer Res; 2009 Nov 01; 69(21):8386-94. PubMed ID: 19826044
    [Abstract] [Full Text] [Related]

  • 18. Androgen receptor-mediated repression of novel target genes.
    Prescott J, Jariwala U, Jia L, Cogan JP, Barski A, Pregizer S, Shen HC, Arasheben A, Neilson JJ, Frenkel B, Coetzee GA.
    Prostate; 2007 Sep 15; 67(13):1371-83. PubMed ID: 17624924
    [Abstract] [Full Text] [Related]

  • 19. Effects of treatment with androgen receptor ligands on microRNA expression of prostate cancer cells.
    Segal CV, Koufaris C, Powell C, Gooderham NJ.
    Toxicology; 2015 Jul 03; 333():45-52. PubMed ID: 25846647
    [Abstract] [Full Text] [Related]

  • 20. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.
    Kang Z, Pirskanen A, Jänne OA, Palvimo JJ.
    J Biol Chem; 2002 Dec 13; 277(50):48366-71. PubMed ID: 12376534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.